Bio

Dr. Mark Smith is Director of the Medicinal Chemistry within the Sarafan ChEM-H Institute Nucleus and Co-Director of the Small Molecule Portfolio in Stanford's Innovative Medicines Accelerator (IMA). In addition, Dr. Smith is Director of the Sarafan ChEM-H Undergraduate Entrepreneurship Program. Prior to Stanford, Dr. Smith was a Senior Scientist at Roche Pharmaceuticals where his research focused on the discovery of small molecule inhibitors for HIV reverse transcriptase, HCV polymerase and NS5A, influenza endonuclease and cap polymerase. Dr. Smith also led Roche's nucleoside chemistry efforts in the virology therapeutic area.

Academic Appointments

Boards, Advisory Committees, Professional Organizations

  • Founder, Riboscience LLC (2014 - Present)

Professional Education

  • Postdoc, University of Illinois at Chicago, Chemistry
  • Ph.D., University of Manchester Institute of Science and Technology (UMIST), Chemistry
  • BSc, University of Greenwich, Chemistry with Business Management

Contact

  • Academic
    mxsmith@stanford.edu
    University - Academic staff Department: ChEM-H Operations Position: Head of Medicinal Chemistry

Additional Info

  • Mail Code: 5085